Q: What is Intuitive Surgical 2026/Q2 Earnings Preview?

TigerAI
07-15

TigerGPT Answer: **Financial Forecast Data**

For Q2 2026, Intuitive Surgical (ISRG) has the following financial forecasts:

- **Earnings Per Share (EPS):** Estimated at $2.50, compared to $2.19 in Q2 2025. This represents a 14.16% increase.

- **Total Revenue:** Estimated at $2,820,324,270, compared to $2,440,000,000 in Q2 2025. This represents a 15.57% increase.

- **EBIT:** Estimated at $1,076,435,240, compared to $946,600,000 in Q2 2025. This represents a 13.71% increase.

**Significance:** The positive growth in EPS, revenue, and EBIT indicates strong financial performance and potential operational efficiency improvements. This growth suggests a positive outlook for the company, potentially driven by increased demand for its products or successful cost management strategies.

**Quarterly Important News**

- **NASDAQ Performance:** On July 14, 2026, Intuitive Surgical was among the bottom performers on the NASDAQ, with a 4.6% decline. This could reflect investor concerns or market reactions to broader economic conditions or company-specific news.

**Impact Analysis:** The decline in stock performance on the NASDAQ could negatively impact investor sentiment. However, the strong financial forecast may counterbalance this, suggesting that the market reaction might be temporary or influenced by external factors.

**Forecast Viewpoints**

There are some articles discussing the company's financial report. However, specific viewpoints and links were not provided in the data.

**Stock Trend Analysis**

- **Stock Price Fluctuation:** From March 31, 2026, to June 29, 2026, ISRG's stock price decreased by 11.94%.

- **Support and Resistance Levels:** The support level is at $476.38, and the resistance level is at $403.22. The latest stock price on July 15, 2026, is $381.33.

**Trend Evaluation:** The stock is currently below the resistance level, indicating a bearish trend. The significant drop in stock price suggests potential investor concerns, possibly related to market conditions or company performance.

**Options Large Order Analysis**

The options data shows significant activity in put options, with both selling and buying of puts at different strike prices. This mixed activity suggests uncertainty among investors, with some expecting a decline (bearish) and others potentially hedging against downside risk.

**Analyst Ratings and Target Price Forecast**

- **Analyst Ratings:** 9 recommend, 15 buy, 10 hold, and 1 underperform.

- **Target Price:** The mean target price is $567.37, with a low of $366.00 and a high of $750.00.

**Valuation Status:** The current stock price of $381.33 is below the mean target price, suggesting the stock may be undervalued. Analysts' ratings are generally positive, indicating confidence in the company's future performance.

**Comprehensive Conclusion**

Intuitive Surgical shows strong financial growth potential with positive EPS, revenue, and EBIT forecasts. Despite recent stock price declines and mixed options activity, the company appears undervalued based on analyst target prices. The overall outlook remains positive, but investors should be cautious of market volatility and external factors impacting stock performance.

**Disclaimer:** The above content is generated by the AI robot TigerGPT and does not represent any personal views. The content is for reference only and does not constitute any investment advice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment